Loading stocks --
Market News
English اردو

Pakistan Pharma Sales Hit Record Rs. 1.251 Trillion in FY26 Despite Low Volume Growth

Pakistan's retail pharmaceutical market touched a record Rs. 1.251 trillion (approx. $4.45 billion) in fiscal year 2026, registering a value growth of 14.88 percent year-on-year, according to data from the Drug Regulatory Authority of Pakistan (DRAP) and industry sources.

Despite the record valuation, total medicine unit sales rose by a mere 0.93 percent to 3.80 billion packs, down from 3.765 billion units previously, indicating severe pressure on household purchasing power and rising treatment costs.

Fiscal YearMarket Size (Rs.)Value Growth (%)
FY24918.22 Billion22.40%
FY251.089 Trillion18.56%
FY261.251 Trillion14.88%

National pharmaceutical companies dominated the market with Rs. 998.54 billion in sales (about 80% share) growing at 16.53 percent, whereas multinational companies recorded sales of Rs. 252.13 billion with a 6.16 percent drop in unit volume. Investors should note that while revenue is driven by pricing adjustments and higher-value drugs, sluggish volume growth highlights consumer constraints.

Read the full story on the original publisher’s website.

Open original article